Valuation: OneSource Specialty Pharma Limited

Market Cap 16TCr 168.79Cr 150.73Cr 139.25Cr 126.19Cr 236.08Cr 239.99Cr 1.68TCr 663.41Cr 8.4TCr 633.46Cr 619.99Cr 26TCr P/E 2027 *
32.9x
P/E 2028 * 15.9x
Enterprise Value 17TCr 178.12Cr 159.06Cr 146.94Cr 133.16Cr 249.13Cr 253.25Cr 1.77TCr 700.07Cr 8.86TCr 668.47Cr 654.26Cr 28TCr EV / Sales 2027 *
7.76x
EV / Sales 2028 * 4.74x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day+4.74%
1 week+2.25%
Current month-8.17%
1 month-10.76%
3 months-17.27%
6 months-23.70%
Current year-22.83%
1 week 1,320.6
Extreme 1320.6
1,404.5
1 month 1,320.6
Extreme 1320.6
1,617.4
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Chairman 65 22/09/2025
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
+4.74%+2.25%-22.74% - 161.16Cr
+2.41%+0.29%+39.41%+73.38% 6.47TCr
-0.31%+6.80%+9.68%+77.18% 5.48TCr
+0.09%+3.36%+9.54%+100.63% 5.35TCr
+0.40%+5.61%+29.15%+52.26% 4.6TCr
-1.07%+0.82%+18.31%+125.02% 4.29TCr
-1.84%-0.32%+213.11%+811.95% 4.01TCr
+0.05%+0.21%+18.06%+48.50% 3.35TCr
+0.22%-4.77%+26.59%+0.55% 2.4TCr
+12.97%+17.35%+59.52%+47.09% 2.37TCr
Average +1.75%+1.65%+40.06%+148.51% 3.85TCr
Weighted average by Cap. +0.92%+2.70%+43.85%+149.89%

Financials

2027 *2028 *
Net sales 2.18TCr 23Cr 21Cr 19Cr 17Cr 32Cr 33Cr 227.96Cr 90Cr 1.14TCr 86Cr 84Cr 3.6TCr 3.4TCr 36Cr 32Cr 30Cr 27Cr 50Cr 51Cr 355.76Cr 140.85Cr 1.78TCr 134.49Cr 131.63Cr 5.62TCr
Net income 445.9Cr 4.7Cr 4.19Cr 3.87Cr 3.51Cr 6.57Cr 6.68Cr 47Cr 18Cr 233.62Cr 18Cr 17Cr 736.55Cr 896.85Cr 9.45Cr 8.44Cr 7.79Cr 7.06Cr 13Cr 13Cr 94Cr 37Cr 469.89Cr 35Cr 35Cr 1.48TCr
Net Debt 885.6Cr 9.33Cr 8.33Cr 7.7Cr 6.97Cr 13Cr 13Cr 93Cr 37Cr 464Cr 35Cr 34Cr 1.46TCr 116.4Cr 1.23Cr 1.09Cr 1.01Cr 91.67L 1.72Cr 1.74Cr 12Cr 4.82Cr 61Cr 4.6Cr 4.5Cr 192.27Cr
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
26/26/26 ₹1,397.30 +4.74% 2,28,373
23/26/23 ₹1,334.10 -3.17% 2,06,529
22/26/22 ₹1,377.80 +1.53% 1,08,051
21/26/21 ₹1,357.10 -0.70% 2,16,713
19/26/19 ₹1,366.60 -2.93% 92,387
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,334.10INR
Average target price
2,056.00INR
Spread / Average Target
+54.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock